Panagora Asset Management Inc Kal Vista Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$8.95 - $11.35 $28,183 - $35,741	-3,149 Reduced 12.07%	22,941 $220,000
Q2 2023 Aug 11, 2023	SELL	$7.73 - $10.57 $155,829 - $213,080	-20,159 Reduced 43.59%	26,090 $234,000
Q1 2023 May 11, 2023	BUY	$6.3 - $8.39 $172,500 - $229,726	27,381 Added 145.12%	46,249 $363,000
Q4 2022 Feb 13, 2023	BUY	$4.2 - $14.24 $79,245 - $268,680	18,868 New	18,868 $127,000
Q3 2021 Nov 10, 2021	SELL	$17.11 - $24.49 $4,756 - $6,808	-278 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$23.12 - $29.91 $531 - $687	-23 Reduced 7.64%	278 $7,000
Q4 2020 Feb 10, 2021	BUY	$12.88 - $19.47 $3,876 - $5,860	301 New	301 $6,000
Q4 2017 Feb 14, 2018	SELL	$6.8 - $13.54 $15,463 - $30,789	-2,274 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.84 - $8.88 $13,280 - $20,193	2,274	2,274 $15,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $229M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.